Novel therapies for the treatment of Alzheimer's disease

Ruijin Zhang

doi:10.1117/12.2692195

7 September 2023 Novel therapies for the treatment of Alzheimer's disease

Ruijin Zhang

Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 127890J (2023) https://doi.org/10.1117/12.2692195
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom

Abstract

Over 50 million people worldwide have been diagnosed with Alzheimer's disease (AD), a sneaky, advancing neurological illness that accounts for the majority of dementia. Since there is no treatment for AD, the primary objective of current drug development is to invent medications that slows down the disease progression. Two clinical manifestations, amyloid beta (Aβ) plaque deposits and neurofibrillary tangles with hyperphosphorylated tau, are the pathological characteristics of AD and serve as biomarkers for neurodegenerative illness. CT1812 is a sigma-2 receptor antagonist, mechanistically aiming to displace Aβ oligomers attached to neuronal receptors to counteract AD progression. Other drugs, following the first Food and Drug Administration (FDA) approved antibody aducanumab targeting amyloid-beta protein, recent results from clinical trials of lecanemab, donanemab and gantenerumab, revelas further information pertaining to the target of the amyloid-beta protein that associates with disease progression. In addition to this, efforts are needed to identify new and effective targets and to scale up drugs that have already undergone initial clinical trials.

Citation Download Citation

Ruijin Zhang "Novel therapies for the treatment of Alzheimer's disease", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 127890J (7 September 2023); https://doi.org/10.1117/12.2692195

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available